Erratum: PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D (Science DOI: 10.1126/science.aah6893);PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D

Science

Volumn 355, Issue 6331, 2017, Pages 1324-1330

  Toska, Eneda ^a   Osmanbeyoglu, Hatice U ^a   Castel, Pau ^a,b   Chan, Carmen ^a   Hendrickson, Ronald C ^a   Elkabets, Moshe ^a,c   Dickler, Maura N ^a   Scaltriti, Maurizio ^a   Leslie, Christina S ^a   Armstrong, Scott A ^a,d   Baselga, José ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPELISIB; CIS ACTING ELEMENT; ESTROGEN RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HISTONE METHYLTRANSFERASE; KMT2D PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR PBX1; UNCLASSIFIED DRUG; AKT1 PROTEIN, HUMAN; CHROMATIN; DNA BINDING PROTEIN; FOXA1 PROTEIN, HUMAN; LYSINE; METHYLTRANSFERASE; MLL2 PROTEIN, HUMAN; ONCOPROTEIN; PBX1 PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PIK3CA PROTEIN, HUMAN; TUMOR PROTEIN;

CANCER; ENZYME ACTIVITY; ESTROGENIC COMPOUND; GENETIC ANALYSIS; INHIBITION; MUTATION; PROTEIN;

AMINO ACID SEQUENCE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CELL VIABILITY; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; CONTROLLED STUDY; ENHANCER REGION; ENZYME ACTIVITY; EPIGENETICS; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MASS SPECTROMETRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; RNA SEQUENCE; TUMOR BIOPSY; TUMOR XENOGRAFT; WILD TYPE; ANIMAL; BREAST NEOPLASMS; FEMALE; GENETIC EPIGENESIS; GENETICS; HEK293 CELL LINE; MCF-7 CELL LINE; METABOLISM; MOUSE; NUDE MOUSE;

ANIMALS; BREAST NEOPLASMS; CHROMATIN; CLASS I PHOSPHATIDYLINOSITOL 3-KINASES; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; FEMALE; HEK293 CELLS; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HUMANS; LYSINE; MCF-7 CELLS; METABOLIC NETWORKS AND PATHWAYS; METHYLTRANSFERASES; MICE; MICE, NUDE; NEOPLASM PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ESTROGEN; TRANSCRIPTION, GENETIC;

EID: 85016264226     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aaw7574     Document Type: Erratum

References (33)

1. Cancer Genome Atlas Network, Nature 490, 61-70 (2012).
2. G. Ciriello et al., Cell 163, 506-519 (2015).
3. D. Juric et al., Cancer Res. 73, LB-64 (2013).
4. P. D. Shah et al., Cancer Res. 75, CT330 (2015).
5. C. Costa et al., Cancer Cell 27, 97-108 (2015).
6. D. Juric et al., Nature 518, 240-244 (2015).
7. A. Bosch et al., Sci. Transl. Med. 7, 283ra51 (2015).
8. F. Janku et al., Cancer Res. 75, PD5-5 (2015).
9. I. A. Mayer et al., Clin. Cancer Res. 23, 26-34 (2016).
10. D. Juric et al., Cancer Res. 73, PD1-3 (2013).
11. J. Baselga et al., J. Clin. Oncol. 34, TPS617 (2016).
12. F. Andre et al., J. Clin. Oncol. 34, TPS618 (2016).
13. K. A. Green, J. S. Carroll, Nat. Rev. Cancer 7, 713-722 (2007).
14. A. Hurtado, K. A. Holmes, C. S. Ross-Innes, D. Schmidt, J. S. Carroll, Nat. Genet. 43, 27-33 (2011).
15. L. Magnani, E. B. Ballantyne, X. Zhang, M. Lupien, PLOS Genet. 7, e1002368 (2011).
16. C. Fritsch et al., Mol. Cancer Ther. 13, 1117-1129 (2014).
17. J. D. Buenrostro, P. G. Giresi, L. C. Zaba, H. Y. Chang, W. J. Greenleaf, Nat. Methods 10, 1213-1218 (2013).
18. J. Eeckhoute et al., Genome Res. 19, 372-380 (2009).
19. M. Lupien et al., Cell 132, 958-970 (2008).
20. H. M. Herz et al., Genes Dev. 26, 2604-2620 (2012).
21. D. Hu et al., Mol. Cell. Biol. 33, 4745-4754 (2013).
22. A. Shilatifard, Annu. Rev. Biochem. 81, 65-95 (2012).
23. R. Mo, S. M. Rao, Y. J. Zhu, J. Biol. Chem. 281, 15714-15720 (2006).
24. J. Zhang et al., Nat. Med. 21, 1190-1198 (2015).
25. S. M. Kooistra, K. Helin, Nat. Rev. Mol. Cell Biol. 13, 297-311 (2012).
26. L. R. Pearce, D. Komander, D. R. Alessi, Nat. Rev. Mol. Cell Biol. 11, 9-22 (2010).
27. T. L. Cha et al., Science 310, 306-310 (2005).
28. W. Kim et al., Nat. Chem. Biol. 9, 643-650 (2013).
29. M. T. McCabe et al., Nature 492, 108-112 (2012).
30. J. M. Spangle et al., Cell Rep. 15, 2692-2704 (2016).
31. A. T. Nguyen, O. Taranova, J. He, Y. Zhang, Blood 117, 6912-6922 (2011).
32. W. J. Harris et al., Cancer Cell 21, 473-487 (2012).
33. K. M. Jozwik, I. Chernukhin, A. A. Serandour, S. Nagarajan, J. S. Carroll, Cell Rep. 17, 2715-2723 (2016).